Biopsy‐proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome—Retrospective single‐center cohort study

Abstract Introduction Persistent tumor after combined chemoradiation for locally advanced cervical cancer is an established prognostic factor. Detection may include magnetic resonance imaging, positron emission tomography (PET) combined with CT scan, ultrasound, or biopsies; however, no agreement ab...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Christoph Ebner, Ricarda Purtscheller, Barin Feroz, Jana Rieker, Linda Ebner, Mara Mantovan, Sergej Skvortsov, Mario Brüggl, Katharina Leitner, Verena Wieser, Irina Tsibulak, Christian Marth, Alain Gustave Zeimet
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2026-02-01
Reeks:	Acta Obstetricia et Gynecologica Scandinavica
Onderwerpen:	biopsy cervical cancer chemoradiation follow‐up persistence radiotherapy
Online toegang:	https://doi.org/10.1111/aogs.70106
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!